# EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding

Study · id `cardio:ct-nct01084993` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01084993](<https://clinicaltrials.gov/study/NCT01084993>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01084993

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT01084993. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2018-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT01084993, source copy `cardio:ctgov-nct01084993-2018-01-31`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01084993, source copy `cardio:ctgov-nct01084993-2018-01-31`, retrieved 2026-10-26)
- Primary completion: 2018-09 (anticipated) (ClinicalTrials.gov record NCT01084993, source copy `cardio:ctgov-nct01084993-2018-01-31`, retrieved 2026-10-26)
- Completion: 2019-01 (anticipated) (ClinicalTrials.gov record NCT01084993, source copy `cardio:ctgov-nct01084993-2018-01-31`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01084993, source copy `cardio:ctgov-nct01084993-2018-01-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01084993-2018-01-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
- Acronym: EASY-B2B
- Condition: Coronary Artery Disease
- Intervention (Drug): Bivalirudin
- Intervention (Drug): Heparin
- Lead sponsor: Laval University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Bivalirudin (`cardio:bivalirudin`)
- Registry intervention name matches this record: Heparin (`cardio:heparin`)
- Registry intervention is a member of this class by a sourced record link: Anticoagulants (`cardio:anticoagulants`)
- Registry lists this organization as the lead sponsor: Laval University (`cardio:org-laval-university`)

## Provenance

Content hash: c99821ccedd73e2bd138e915cce6945c18d2ed499561860285285a1df722ff27
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
